3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Waldenstrom Macroglobulinemia
1
Uveal Melanoma
1
Triple Negative Breast Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Glioma
1
Glioblastoma
1
Epstein-Barr Virus Infections
1
Cytomegalovirus Infections
1
Carcinoma, Non-Small-Cell Lung
1
Astrocytoma
1
Interventions
Voriconazole
2
Daptomycin
2
threonic acid
1
telavancin
1
telaprevir
1
soybean oil, phospholipid emulsion
1
plerixafor
1
peginterferon alfa-2a
1
human papillomavirus vaccine, L1 type 16, 18
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Trimethoprim
1
Tacrolimus
1
Sulfamethoxazole
1
Sirolimus
1
Rituximab
1
Ribavirin
1
Peripheral Blood Stem Cell Transplantation
1
Ofloxacin
1
Methotrexate
1
Melphalan
1
Magnesium Sulfate
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Hematopoietic Stem Cell Transplantation
1
Granulocyte Colony-Stimulating Factor
1
Fluconazole
1
Filgrastim
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Infections
×
Valacyclovir
×
Clear all
No trials found.